<DOC>
	<DOCNO>NCT00697983</DOCNO>
	<brief_summary>Background : Osteoporosis high-prevalence disease strong genetic component . Nucleotides , include ATP ( adenosine 5'-triphosphate ) purinergic receptor , play role bone physiology . Single nucleotide polymorphism ( SNPs ) P2X7 receptor gene recently find associated fracture risk cohort postmenopausal woman . Objective : To investigate association purinergic receptor SNPs osteoporosis risk human . Genetic data fracture cohort Netherlands high prevalence osteoporosis analyze . Furthermore , effect aberrant purinergic receptor signal bone turnover marker assess ex vivo . Design : The cohort include app . 1,000 fracture patient 50 year old , recruit Maastricht University Medical Center standard medical follow-up clinical fracture . The standard medical follow-up include assessment bone mineral density ( BMD ) Dual-Energy X-ray Absorptiometry ( DXA ) , necessary follow medication osteoporosis . Prior medication , blood sample collect fracture patient genotyped purinergic receptor SNPs analyze biochemical marker bone turnover . Systemic correlate osteoporosis compare osteoporotic subject ( i.e . low BMD ) non-osteoporotic control ( i.e . normal high BMD ) . Subsequently , whole blood assay patient subgroup ( n=20 per subgroup ) , base BMD purinergic receptor SNPs , perform evaluate ex vivo effect ATP relate nucleotide bone marker . Study population : Patients 50 year old attend outpatient osteoporosis clinic Maastricht University Medical Center standard medical follow-up clinical , non-pathological fracture . Primary outcome parameter : BMD purinergic receptor SNPs . Secondary outcome parameter : Bone marker .</brief_summary>
	<brief_title>Cohort Study Associations Between Purinergic Receptor SNPs Osteoporosis Risk</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Age 50 year old ; Clinical fracture ; Attending osteoporosis outpatient clinic standard medical care . Disease bone metabolism ( e.g . bone tumour , hyperparathyroidism ) ; Unwillingness donate blood DNA analyse ; Failure bone densitometry ( DXAscan ) .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>ATP</keyword>
	<keyword>Purinergic receptor</keyword>
	<keyword>Bone mineral density</keyword>
	<keyword>Single nucleotide polymorphism</keyword>
</DOC>